4//SEC Filing
CROSKREY STEPHEN 4
Accession 0001213900-20-045824
CIK 0001779020other
Filed
Dec 30, 7:00 PM ET
Accepted
Dec 31, 6:07 PM ET
Size
13.3 KB
Accession
0001213900-20-045824
Insider Transaction Report
Form 4
CROSKREY STEPHEN
Director
Transactions
- Award
Class A Common Stock ("Common Stock")
2020-12-29+4,432,261→ 4,432,261 total - Award
Stock Option
2020-12-29+2,571,737→ 2,571,737 totalExercise: $24.20Exp: 2030-12-29→ Common Stock (2,571,737 underlying) - Award
Stock Option
2020-12-29+1,154,616→ 1,154,616 totalExercise: $24.20Exp: 2030-12-29→ Common Stock (1,154,616 underlying) - Other
Common Stock
2020-12-29$24.20/sh−944,144$22,848,285→ 3,488,117 total
Footnotes (6)
- [F1]Received in exchange for shares of common stock of Meredian Holdings Group, Inc., a Georgia corporation ("MHG") pursuant to the Agreement and Plan of Merger, dated as of October 3, 2020, by and among Live Oak Acquisition Corp., a Delaware corporation ("Live Oak"), Green Merger Corp., a Georgia corporation and wholly owned subsidiary of Live Oak ("Merger Sub"), MHG, Live Oak Sponsor Partners, LLC, as representative for Live Oak, and John A. Dowdy, Jr., as representative of the shareholders of the Company, as amended by Amendment No. 1, dated as of October 8, 2020, and Amendment No. 2, dated as of December 11, 2020, by and among all the parties thereto (as amended, the "Merger Agreement"), pursuant to which MHG became a direct, wholly-owned subsidiary of Live Oak, which subsequently changed its name to Danimer Scientific, Inc. (the "Issuer").
- [F2]These shares of Common Stock were surrendered by the Reporting Person to the Issuer in satisfaction of outstanding indebtedness.
- [F3]Options to purchase 857,245 shares of Common Stock will vest and become exercisable on or after December 29, 2021 if the closing price of a share of Common Stock equals or exceeds $14.00 for any twenty (20) trading dates within a thirty (30)-day trading period beginning on December 29, 2021, options to purchase 857,246 shares of Common Stock will vest and become exercisable on or after December 29, 2022 if the closing price of a share of Common Stock equals or exceeds $17.00 for any twenty (20) trading dates within a thirty (30)-day trading period beginning on December 29, 2021 and options to purchase 857,246 shares of Common Stock will vest and become exercisable on or after December 29, 2023 if the closing price of a share of Common Stock equals or exceeds $20.00 for any twenty (20) trading dates within a thirty (30)-day trading period beginning on December 29, 2021.
- [F4]Granted pursuant to the terms of the Merger Agreement and issued under the Plan.
- [F5]The option will not be exercisable until the later to occur of February 1, 2024 or the approval by the shareholders of the Issuer of an amendment to the Plan to increase the number of shares available under the Plan in an amount sufficient to permit the exercise of the option.
- [F6]Granted in connection with the business combination contemplated by the Merger Agreement and issued under the Plan.
Documents
Issuer
Danimer Scientific, Inc.
CIK 0001779020
Entity typeother
Related Parties
1- filerCIK 0001140350
Filing Metadata
- Form type
- 4
- Filed
- Dec 30, 7:00 PM ET
- Accepted
- Dec 31, 6:07 PM ET
- Size
- 13.3 KB